Codon 72 polymorphism of P53 gene does not affect the risk of cirrhosis and hepatocarcinoma in HCV-infected patients

Michela Leveri, Chiara Gritti, Laura Rossi, Claudio Zavaglia, Emilio Civardi, Mario U. Mondelli, Annalisa De Silvestri, Enrico M. Silini

Research output: Contribution to journalArticle

Abstract

Chronic hepatitis C virus (HCV) infection is the most frequent cause of progressive liver disease and liver cancer in the West. The p53 tumor supressor gene is known to play an important role in carcinogenesis of different tissues being involved in gene transcription, DNA synthesis and repair and somatic mutations of p53 are common in primary liver cancer. The p53 gene displays a common genetic Arg/Pro polymorphism at codon 72 with functional significance, that has been investigated as risk factor in several cancer models. We analyzed p53 codon 72 polymorphism in a group of 340 HCV-infected subjects at different stages of disease, including 84 hepatocellular carcinoma patients. No association between codon 72 genotypes and disease severity or liver cancer was observed.

Original languageEnglish
Pages (from-to)75-79
Number of pages5
JournalCancer Letters
Volume208
Issue number1
DOIs
Publication statusPublished - May 10 2004

Keywords

  • DNA polymorphisms
  • Hepatitis C virus
  • Hepatocellular carcinoma
  • p53

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology
  • Oncology

Fingerprint Dive into the research topics of 'Codon 72 polymorphism of P53 gene does not affect the risk of cirrhosis and hepatocarcinoma in HCV-infected patients'. Together they form a unique fingerprint.

  • Cite this